ArticleNature communications2026
Unified bilayer membranes with mechanically reinforced interface for stage-adaptive bone regeneration.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
16 authors.
Funding
Abstract
Guided bone regeneration using double-layered membranes is often hindered by poor interfacial integration, insufficient stability, and limited adaptability to regulate the complex healing process. Herein, we develop a unified bilayer membrane featuring a reinforced dual-crosslinking interface between barrier and porous layers through a homogeneous isomeric in-situ fabrication strategy. Its superior mechanical strength (~156 MPa in dry state and ~8.6 MPa in wet state) ensures the long-term degradation stability and bioactivity in vivo. Combined with sequentially released bioactive components, we show that the unified bilayer membrane regulates antibacterial functions, immunomodulation, neurovascularization, and osteogenesis, thereby enabling stage-adaptive bone regeneration. We test in a rat critical-sized cranial defect model to demonstrate that the membrane significantly outperforms the clinical collagen membrane, achieving ~2.7-fold greater bone volume regeneration after 8 weeks. This work further elucidates the spatiotemporal osteogenic mechanisms of the unified bilayer membrane, which constructs a well-integrated regenerative microenvironment and promotes a tightly interconnected neurovascular-osteogenic communication network during stage-adaptive bone repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.